Edition:
United States

Cyclacel Pharmaceuticals Inc (CYCC.OQ)

CYCC.OQ on NASDAQ Stock Exchange Capital Market

1.50USD
20 Jul 2018
Change (% chg)

$0.01 (+1.01%)
Prev Close
$1.49
Open
$1.50
Day's High
$1.54
Day's Low
$1.50
Volume
445
Avg. Vol
14,433
52-wk High
$2.26
52-wk Low
$1.29

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Mar '18 0.00 -0.117
FY 2017 Dec '17 0.00 -0.175
Sep '17 0.00 -0.907
Jun '17 0.00 -0.504
Mar '17 0.00 -0.376
FY 2016 Dec '16 0.28 -0.678
Sep '16 0.20 -0.862
Jun '16 0.22 -1.005
Mar '16 0.14 -1.042
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-18 1 0.00 0.00 0.00 --
Quarter Ending Dec-18 1 0.00 0.00 0.00 --
Year Ending Dec-18 1 0.00 0.00 0.00 2.00
Year Ending Dec-19 1 0.00 0.00 0.00 2.00
Earnings (per share)
Quarter Ending Sep-18 1 -0.11 -0.11 -0.11 --
Quarter Ending Dec-18 1 -0.09 -0.09 -0.09 --
Year Ending Dec-18 1 -0.43 -0.43 -0.43 -1.57
Year Ending Dec-19 1 -0.37 -0.37 -0.37 -1.18
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 214.53 33.05
P/E High - Last 5 Yrs. -- 284.38 47.17
P/E Low - Last 5 Yrs. -- 96.91 24.95
Beta 3.70 0.76 0.81
Price to Sales (TTM) -- 254.39 8.10
Price to Book (MRQ) 0.88 21.00 4.20
Price to Tangible Book (MRQ) 0.88 27.24 6.22
Price to Cash Flow (TTM) -- 130.02 22.23
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.36 1.74
Dividend Yield - 5 Year Avg -- 0.21 1.46
Dividend 5 Year Growth Rate -- 2.25 -6.34
Payout Ratio(TTM) -- 83.66 47.29

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 33.06 4.76
Sales (TTM) vs TTM 1 Yr. Ago -100.00 147.32 12.20
Sales - 5 Yr. Growth Rate -- 30.74 7.68
EPS (MRQ) vs Qtr. 1 Yr. Ago 68.97 -78.41 49.25
EPS (TTM) vs TTM 1 Yr. Ago 41.71 -- --
EPS - 5 Yr. Growth Rate -- 46.75 7.98
Capital Spending - 5 Yr. Growth Rate 1.61 42.59 7.61

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.72 2.56
Current Ratio (MRQ) 5.81 6.63 3.63
LT Debt to Equity (MRQ) 0.00 24.37 13.18
Total Debt to Equity (MRQ) 0.00 28.57 17.32
Interest Coverage (TTM) -- -156.06 35.18

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 55.96 55.27
Gross Margin - 5 Yr. Avg. -- 53.49 53.21
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -1,420.21 -180.79 15.63
Operating Margin (TTM) -- -952.42 -0.59
Operating Margin - 5 Yr. Avg. -1,431.26 -194.47 10.78
Pre-Tax Margin (TTM) -- -846.49 1.29
Pre-Tax Margin - 5 Yr. Avg. -1,306.91 -199.31 10.90
Net Profit Margin (TTM) -- -837.92 -2.01
Net Profit Margin - 5 Yr. Avg. -1,127.90 -197.08 7.26
Effective Tax Rate (TTM) -- 14.85 20.80
Effective Tax Rate - 5 Yr. Avg. -- 19.02 24.29

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 23,390,416 736,883,287
Net Income/Employee (TTM) -605,333 -1,131,911 85,936,826
Receivable Turnover (TTM) -- 17.85 5.95
Inventory Turnover (TTM) -- 2.85 3.69
Asset Turnover (TTM) 0.00 0.48 0.87

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -34.71 -2.22 10.35
Return on Assets - 5 Yr. Avg. -47.89 2.95 11.02
Return on Investment (TTM) -43.41 -3.67 13.17
Return on Investment - 5 Yr. Avg. -63.52 2.77 14.24
Return on Equity (TTM) -88.15 -5.61 15.10
Return on Equity - 5 Yr. Avg. -81.57 -4.39 15.57
  1 Year 3 Year 5 Year
Sales % -100.00 -- --
EPS (TTM) % 44.43 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Cyclacel Pharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 4.74%
# of Holders: 18
Total Shares Held: 568,713
3 Mo. Net Change: -12,677
# New Positions: 0
# Closed Positions: 1
# Increased Positions: 0
# Reduced Positions: 1
# Net Buyers: -1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.